chr12-66138046-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016056.4(TMBIM4):c.631G>A(p.Val211Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,461,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016056.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMBIM4 | NM_016056.4 | c.631G>A | p.Val211Ile | missense_variant | 7/7 | ENST00000358230.8 | NP_057140.2 | |
TMBIM4 | NM_001282606.2 | c.772G>A | p.Val258Ile | missense_variant | 8/8 | NP_001269535.1 | ||
TMBIM4 | NM_001282610.2 | c.538G>A | p.Val180Ile | missense_variant | 7/7 | NP_001269539.1 | ||
TMBIM4 | NM_001282609.2 | c.*107G>A | 3_prime_UTR_variant | 7/7 | NP_001269538.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMBIM4 | ENST00000358230.8 | c.631G>A | p.Val211Ile | missense_variant | 7/7 | 1 | NM_016056.4 | ENSP00000350965 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249508Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135364
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461832Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 727226
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.631G>A (p.V211I) alteration is located in exon 7 (coding exon 7) of the TMBIM4 gene. This alteration results from a G to A substitution at nucleotide position 631, causing the valine (V) at amino acid position 211 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at